AWM
GSK icon

Aberdeen Wealth Management’s GSK GSK Stock Holding History

Aberdeen Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21K Buy
+400
New +$21.2K 0.01% 285
2020
Q3 		– Sell
-4,110
Closed -$210K – 138
2020
Q2 		$210K Buy
+4,110
New +$211K 0.23% 116
2020
Q1 		– Sell
-4,007
Closed -$235K – 128
2019
Q4 		$235K Buy
+4,007
New +$223K 0.18% 126

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Aberdeen Wealth Management's GSK Position: Q2 2026 in Review

Aberdeen Wealth Management opened a new position in GSK (GSK) in Q2 2026: 400 shares worth $21K. The stake represents 0.01% of the portfolio and ranks #285 among its holdings. This is a return to the name: Aberdeen Wealth Management previously reported a position in GSK as recently as Q2 2020.

Aberdeen Wealth Management first reported a position in GSK in Q4 2019 and has held it in 3 quarters since. The position peaked at $235K in Q4 2019. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Aberdeen Wealth Management held 400 shares of GSK worth $21K as of Q2 2026.
  • GSK was a new Aberdeen Wealth Management position in Q2 2026.
  • GSK made up 0.01% of Aberdeen Wealth Management's portfolio in Q2 2026, its #285 holding.
  • Aberdeen Wealth Management first reported a position in GSK in Q4 2019 and has held it in 3 quarters since.
  • Aberdeen Wealth Management's GSK position peaked at $235K in Q4 2019.
  • 1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Aberdeen Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.